These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 22457856)
1. IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits. Necula LG; Chivu-Economescu M; Stanciulescu EL; Bleotu C; Dima SO; Alexiu I; Dumitru A; Constantinescu G; Popescu I; Diaconu CC J Gastrointestin Liver Dis; 2012 Mar; 21(1):23-9. PubMed ID: 22457856 [TBL] [Abstract][Full Text] [Related]
2. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138 [TBL] [Abstract][Full Text] [Related]
3. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort. Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236 [TBL] [Abstract][Full Text] [Related]
4. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. Jackson CB; Judd LM; Menheniott TR; Kronborg I; Dow C; Yeomans ND; Boussioutas A; Robb L; Giraud AS J Pathol; 2007 Oct; 213(2):140-51. PubMed ID: 17724739 [TBL] [Abstract][Full Text] [Related]
5. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. Howlett M; Giraud AS; Lescesen H; Jackson CB; Kalantzis A; Van Driel IR; Robb L; Van der Hoek M; Ernst M; Minamoto T; Boussioutas A; Oshima H; Oshima M; Judd LM Gastroenterology; 2009 Mar; 136(3):967-77. PubMed ID: 19121317 [TBL] [Abstract][Full Text] [Related]
6. Cytokine signalling via gp130 in gastric cancer. Howlett M; Menheniott TR; Judd LM; Giraud AS Biochim Biophys Acta; 2009 Nov; 1793(11):1623-33. PubMed ID: 19665497 [TBL] [Abstract][Full Text] [Related]
7. Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression. Judd LM; Ulaganathan M; Howlett M; Giraud AS J Pathol; 2009 Mar; 217(4):552-62. PubMed ID: 19097069 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Gatti LL; Burbano RR; Zambaldi-Tunes M; de-Lábio RW; de Assumpção PP; de Arruda Cardoso-Smith M; Marques-Payão SL Arch Med Res; 2007 Jul; 38(5):551-5. PubMed ID: 17560462 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutations. Buzzelli JN; O'Connor L; Scurr M; Chung Nien Chin S; Catubig A; Ng GZ; Oshima M; Oshima H; Giraud AS; Sutton P; Judd LM; Menheniott TR Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G251-G262. PubMed ID: 30520693 [TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-6 levels reflect disease status of gastric cancer. Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006 [TBL] [Abstract][Full Text] [Related]
12. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528 [TBL] [Abstract][Full Text] [Related]
13. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174 [TBL] [Abstract][Full Text] [Related]
14. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. An JY; Choi MG; Noh JH; Sohn TS; Jin DK; Kim S J Surg Res; 2007 Dec; 143(2):344-9. PubMed ID: 17688884 [TBL] [Abstract][Full Text] [Related]
16. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori. Mehmet N; Refik M; Harputluoglu M; Ersoy Y; Aydin NE; Yildirim B New Microbiol; 2004 Apr; 27(2):139-48. PubMed ID: 15164624 [TBL] [Abstract][Full Text] [Related]
17. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Fox JG; Sheppard BJ; Dangler CA; Whary MT; Ihrig M; Wang TC Cancer Res; 2002 Feb; 62(3):696-702. PubMed ID: 11830522 [TBL] [Abstract][Full Text] [Related]
18. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma. de Mingo M; Morán A; Sánchez-Pernaute A; Iniesta P; Díez-Valladares L; Pérez-Aguirre E; de Juan C; García-Aranda C; Díaz-López A; García-Botella A; Martín-Antona E; Benito M; Torres A; Balibrea JL Hepatogastroenterology; 2007; 54(73):315-9. PubMed ID: 17419282 [TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718 [TBL] [Abstract][Full Text] [Related]
20. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma. Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]